KAM
ABBV icon

Krensavage Asset Management’s AbbVie ABBV Stock Holding History

Krensavage Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-70,000
Closed -$4.1M – 23
2015
Q1 		$4.1M Sell
70,000
-5,500
-7% -$332K 1.87% 17
2014
Q4 		$4.94M Buy
+75,500
New +$4.76M 2.75% 16

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Krensavage Asset Management's ABBV Position: Q2 2015 in Review

Krensavage Asset Management sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 70,000 shares — an estimated $4.1M sold.

Krensavage Asset Management first reported a position in ABBV in Q4 2014 and held it in 2 quarters. The position peaked at $4.94M in Q4 2014. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Krensavage Asset Management reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Krensavage Asset Management sold 70,000 AbbVie shares in Q2 2015, an estimated $4.1M.
  • Krensavage Asset Management first reported a position in AbbVie in Q4 2014 and held it in 2 quarters.
  • Krensavage Asset Management's AbbVie position peaked at $4.94M in Q4 2014.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Krensavage Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.